Trial
NCT04275778
HYDROxychloroquine in Syndrome Primary AntiPhospholipid
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Antiphospholipid Syndrome in Pregnancy
Intervention
Plaquenil 200Mg Tablet
Why stopped
The study was terminated following revisions to the diagnostic criteria defining the target pathology, which significantly impacted the study design
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-06